Indefinite Delivery Contract SPE2DE21D0042

Award Date 7/26/21
Last Date to Order 7/25/26
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single-award Blanket Purchase Agreement (BPA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, to provide cost-per-test clinical laboratory analyzers and associated products and services. The $939,392.25 BPA covers the supply of in-vitro diagnostic testing equipment, reagents, and accessories through February 2030. The original solicitation sought to...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, to provide cost-per-test blood analyzers and associated medical laboratory equipment and supplies. The $544,737 single-award IDC was issued to Grifols without any set-aside designations and has an ultimate completion date of January 29, 2025. Grifols, a global healthcare company, has received over $8 million in prior federal awards...
Grifols Diagnostic Solutions Inc. was awarded a multiple award federal supply schedule contract under GSA schedule 65-VII for in vitro diagnostics, reagents, tests, kits, and sets by the Department of Veterans Affairs Veterans Health Administration. The contract has a potential value of $1.15M and period of performance from March 2020 through March 2025. Under the contract, Grifols provides a range of diagnostic products including blood typing and screening materials, control cells, monoclonal...
The Department of the Air Force Air Education and Training Command awarded a single-award Blanket Purchase Agreement (BPA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, to provide Procleix Zika Assay reagent kits. The $840,000 BPA has a performance period through March 2024 and does not utilize any set-asides. Grifols is a global healthcare company that has received over $8 million in federal prime contracts to supply a range of critical medical laboratory...
The Department of Veterans Affairs (VA) awarded a multiple-award Federal Supply Schedule (FSS) contract #36F79720D0067 under GSA Schedule 66-III Critical Analyzers, Laboratory to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company. The $1.25 million IDV has a period of performance through April 2025 and facilitates the procurement of automated and semi-automated blood bank analyzers, consumables, and related services for VA medical centers across the United States and its...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for the supply of blood bank reagents. The contract, valued at up to $36,593.10, has an ultimate completion date of May 31, 2022 and was awarded on June 1, 2020. The BPA was established under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. Grifols, a global healthcare company, has...
Grifols Diagnostic Solutions Inc. was awarded a blanket purchase agreement (BPA) under the Critical Analyzers, Laboratory Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The BPA has a potential value of $447,337.52 and period of performance through April 30, 2028. Under the BPA, Grifols will provide blood bank testing services to support healthcare programs for veterans in the Oakland, California region. A...
The Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, awarded this indefinite delivery/indefinite quantity (IDIQ) contract SPE2DE19D0004 to Government Scientific Source Inc. (GSS), a leading distributor of laboratory products and equipment. The contract has a total ceiling value of $475,000,000 and is a single-award IDIQ with no set-aside designation. Under this contract, GSS will provide a variety of laboratory supplies, equipment, and services...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The $48,125,000 contract is for the delivery of a variety of diagnostic products and services, including the XTAG Cystic Fibrosis Kit, NXTAG Respiratory Pathogen Panel, MAGPIX microspheres, and performance verification for Luminex 100/200 systems. The contract does not utilize any small business...
This federal contract IDV award, valued at up to $7,326,120.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Alba Bioscience, Inc., a foreign-owned, for-profit organization. The contract is an Indefinite Delivery Contract with a period of performance through November 28, 2026. Alba Bioscience provides a variety of in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to support the DLA's medical supply needs. Task orders...
  • SPE2DE21D0042
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Defense Logistics Agency Troop Support Medical awarded a $5 million Indefinite Delivery Contract to Grifols Diagnostic Solutions Inc., a foreign-owned, for-profit subsidiary of the global healthcare company Grifols. The contract, which has an ultimate completion date of July 25, 2026, is for the procurement of laboratory supplies, including reagents, diagnostics, chemicals, biologicals, apparatus, equipment, and instruments, to be ordered through the DLA Electronic Catalog for various Department of Defense and federal customers.

This award is part of a larger $491.8 million (maximum $983.6 million) Multiple Award Schedule program established by the DLA Troop Support Medical to qualify suppliers of laboratory supplies for a five-year period. The program aims to provide logistical support and allow customers to select products that best meet their mission needs. As a current supplier, Grifols Diagnostic Solutions Inc. has demonstrated extensive capabilities in providing critical medical diagnostic technologies, such as blood bank analyzers, nucleic acid testing systems, and immunofluorescence analyzers, to various federal healthcare systems, including the Department of Veterans Affairs and Department of Defense.

Generated 7/3/25, 3:01 PM